Nutriband (NTRB) Provides Product Development Update for Aversa Fentanyl

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. ABBV
2. SLGN
3. EYPT
4. CRWV
5. MANE
6. LTFH:IN
7. PNB:IN
8. LTM:IN
9. VEON
10. GP

Go back to Nutriband (NTRB) Provides Product Development Update for Aversa Fentanyl

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

June 20, 2024 7:02 AM EDT

ORLANDO, FL / ACCESSWIRE / June 20, 2024 / Nutriband Inc.("Company") (NASDAQ: NTRB)(NASDAQ: NTRBW) provides an update on its Aversa Fentanyl product development program to shareholders as it aims to complete scale-up of the commercial manufacturing process and move towards the single Phase 1 human abuse potential study prior to NDA filing.

As previously reported, the Company with its partner Kindeva Drug Delivery completed the feasibility agreement and entered into a commercial development and clinical supply agreement to manufacture product for the human abuse potential... More